Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
13C-Spirulina Gastric Emptying Breath Test
- Development stage
- Unknown
- Lead developer
- Cairn Diagnostics
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
The 13C-Spirulina Gastric Emptying Breath Test (GEBT) is a non-invasive diagnostic tool developed by Cairn Diagnostics (formerly Advanced Breath Diagnostics) for the evaluation of gastric emptying rates in patients with suspected gastroparesis. The test utilizes *Spirulina platensis*, an edible blue-green alga, which has been enriched with the stable, non-radioactive isotope carbon-13 (13C). Upon oral ingestion as part of a standardized test meal, the 13C-labeled algae are emptied from the stomach, digested in the small intestine, and metabolized. The resulting 13CO2 is absorbed into the blood and subsequently exhaled. By measuring the ratio of 13CO2 to 12CO2 in breath samples collected over several hours using isotope ratio mass spectrometry (IRMS) or infrared spectrometry, clinicians can calculate the gastric emptying rate. This provides a safe, non-radioactive alternative to the traditional gold standard, gastric emptying scintigraphy, and was FDA approved in 2015.
- Brand names
- GEBT
- Other names
- 13C-Spirulina Breath TestCairn GEBT13C-Spirulina platensis Gastric Emptying Breath Test
Beyond the preview
Go deeper on 13C-Spirulina Gastric Emptying Breath Test.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 13C-Spirulina Gastric Emptying Breath Test.